Skip to main content
Signal8

Ryali Sriram

SEC insider (Form 3/4/5 filer). CIK 0001762893. Chief Financial Officer at Caribou Biosciences, Inc. (CRBU). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 20, 2026. Located in BERKELEY, CA.

Companies Ryali Sriram has filed insider reports for

  • Caribou Biosciences, Inc. (CRBU): Officer, Chief Financial Officer
Ryali Sriram profile photo

Ryali Sriram

CIK: 0001762893

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Caribou Biosciences, Inc. logo
CRBU

Caribou Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Caribou Biosciences, Inc. logo
    CRBU

    Caribou Biosciences, Inc.

    Feb 20, 2026
    Award
    Direct
    55K shares-
  • Caribou Biosciences, Inc. logo
    CRBU

    Caribou Biosciences, Inc.

    Jan 29, 2025
    Purchase
    Direct
    17.4K shares at avg. $1.42$25K
  • Caribou Biosciences, Inc. logo
    CRBU

    Caribou Biosciences, Inc.

    Jan 10, 2025
    Award

    Option to purchase Common Stock

    Direct
    300K shares-

1-3 of 3